Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness,
impairs quality-of-life, and increases cardiovascular disease and road traffic accident risks …

Mandibular advancement devices (MADs) represent the main non-continuous positive
airway pressure (non-CPAP) therapy for patients with obstructive sleep apnoea (OSA). The …

BACKGROUND Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime
sleepiness (EDS), impairs quality of life (QoL) and increases cardiovascular disease and …

The aim of this study was to compare mandibular advancement device (MAd) therapy and
continuous positive airway pressure (CPAP) for obstructive sleep apnoea/hypopnoea …

Abstract Study Objectives The impact of therapy with continuous positive airway pressure
(CPAP) and mandibular advancement device (MAD) has not been directly compared in …

Background: Previous randomized controlled trials have addressed the efficacy of
mandibular advancement devices (MADs) in the treatment of obstructive sleep apnea (OSA) …

The treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure
(CPAP) or mandibular advancement devices (MADs) is associated with blood pressure (BP) …

The purpose of this review is to conduct a systematic review and meta-analysis comparing
the effects of continuous positive airway pressure (CPAP) with a mandibular advancement …

Rationale Mandibular advancement devices (MADs) are used to treat obstructive sleep
apnoea-hypopnoea syndrome (OSAHS) but evidence is lacking regarding their clinical and …

Continuous positive airway pressure (CPAP) remains the gold standard treatment for
obstructive sleep apnoea hypopnoea syndrome (OSAHS). However, the high efficacy of …